Innovation Pharmaceuticals Inc (IPIX)

[macnqueso]

The winds are starting to change... We should remember too that we are now exiting the summer doldrums... and within a month of entering what some consider to be the "five best months" of the market year, which will bring some investors back from the summer hiatus... even with big block selling the pps didn't move down much... in the days ahead I think the big block buying will become more common... with buying pressure the traders will return and the pps one's will be history before year's end... If Leo could make the Aspire deal when he did, then he will certainly make a good deal for financing as needed now... the company is much deeper and more developed than it was back then... and it is not really even close... the polymedix deal was ridiculous... and I do mean ridiculously good... investors are beginning to figure out what this little company has going... over the weekend I posted a simple list of likely catalysts over the next 15 months... I made the list for myself... and posted it without comment... it is filled with material events... by the end of 2014...

p1 Kevetrin @ DF will be completed and MTD will be established
p1b Kevetrin @ Bologna will be underway
p1 Kevetrin @ Beth Israel will be underway
pre-clinical findings for Kevetrin from MD Anderson will be pr'd
p2/3 for Purisol will be underway w/p2 likely finished and data
p2b for Brilacidin in ASSSBI will be completed w/findings
p2 for Brilacidin in Oral Mucositis will be completed w/findings

Does anyone really believe the market can possibly ignore all of this clinical activity? Throw-in the uplist and the first licensing deal - and there is every indication that CTIX is headed for a banner year in 2014.

Maybe I'm wrong and all three indications will fail miserably, but I doubt it... I have never seen a biotech this small with so much meaningful clinical activity in the que... my guess is that patience will be richly rewarded with this one...